| A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates M Pino, T Abid, S Pereira Ribeiro, VV Edara, K Floyd, JC Smith, MB Latif, ... Science immunology 6 (61), eabh3634, 2021 | 62 | 2021 |
| Activated human astrocyte-derived extracellular vesicles modulate neuronal uptake, differentiation and firing Y You, K Borgmann, VV Edara, S Stacy, A Ghorpade, T Ikezu Journal of extracellular vesicles 9 (1), 1706801, 2020 | 137 | 2020 |
| Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans PS Arunachalam, MKD Scott, T Hagan, C Li, Y Feng, F Wimmers, ... Nature 618 (7964), E18, 2023 | 1 | 2023 |
| Adjuvanting a subunit COVID-19 vaccine to induce protective immunity PS Arunachalam, AC Walls, N Golden, C Atyeo, S Fischinger, C Li, P Aye, ... Nature 594 (7862), 253-258, 2021 | 280 | 2021 |
| Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates PS Arunachalam, AC Walls, N Golden, C Atyeo, S Fischinger, C Li, P Aye, ... bioRxiv, 2021.02. 10.430696, 2021 | 20 | 2021 |
| Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates (preprint) PS Arunachalam, AC Walls, N Golden, C Atyeo, S Fischinger, C Li, P Aye, ... | | 2021 |
| Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19 N Doria-Rose, MS Suthar, M Makowski, S O’Connell, AB McDermott, ... New England Journal of Medicine 384 (23), 2259-2261, 2021 | 699 | 2021 |
| Antibody response to COVID-19 mRNA vaccine in patients with lung cancer after primary immunization and booster: reactivity to the SARS-CoV-2 WT virus and Omicron variant RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ... Journal of Clinical Oncology 40 (33), 3808, 2022 | 23 | 2022 |
| Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: reactivity to vaccine antigen and variants of concern RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ... MedRxiv, 2022.01. 03.22268599, 2022 | 14 | 2022 |
| Astrocyte HIV-1 Proviral Reservoirs in HAND VVC Edara, K Borgmann, A Ghorpade | | 2019 |
| Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India K Nayak, K Gottimukkala, S Kumar, ES Reddy, VV Edara, R Kauffman, ... Virology 558, 13-21, 2021 | 26 | 2021 |
| Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India (preprint) K Nayak, K Gottimukkala, S Kumar, ES Reddy, VV Edara, R Kauffman, ... | | 2020 |
| Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera B Mühlemann, SH Wilks, L Baracco, M Bekliz, JM Carreño, VM Corman, ... bioRxiv, 2023 | 1 | 2023 |
| Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera (preprint) B Mühlemann, SH Wilks, L Baracco, M Bekliz, JM Carreno, VM Corman, ... | | 2023 |
| Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays B Mühlemann, SH Wilks, L Baracco, M Bekliz, JM Carreño, VM Corman, ... Science Translational Medicine 16 (747), eadl1722, 2024 | 1 | 2024 |
| Covaxin (BBV152) vaccine neutralizes SARS-CoV-2 Delta and Omicron variants VV Edara, M Patel, MS Suthar medRxiv, 2022.01. 24.22269189, 2022 | 10 | 2022 |
| Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 137 | 2022 |
| Determinants of neutralizing antibody response after SARS CoV-2 vaccination in patients with myeloma AK Nooka, U Shanmugasundaram, N Cheedarla, H Verkerke, VV Edara, ... Journal of Clinical Oncology 40 (26), 3057, 2022 | 38 | 2022 |
| Development of a rapid focus reduction neutralization test assay for measuring SARS‐CoV‐2 neutralizing antibodies A Vanderheiden, VV Edara, K Floyd, RC Kauffman, G Mantus, ... Current protocols in immunology 131 (1), e116, 2020 | 113 | 2020 |
| Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 528 | 2021 |
